Rising coronavirus infections in some regions could lead to a fourth spike in US incidence
The Biden administration hit an important milestone on Friday – by April 2, 100 million US residents had received at least one dose of the COVID-19 vaccine.
The United States became the first country in the world to achieve such success in vaccination. However, in some regions of the United States, the number of cases of COVID-19 infection continues to rise.
President Joe Biden said earlier this week that at least 90% of American adults will be eligible for the vaccine by April 19, due to the increase in vaccination rates. Earlier, Biden promised to achieve this figure by May 1.
However, during a briefing by the coronavirus working group at the White House earlier this week, the head of the U.S. Centers for Disease Control and Prevention (CDC) Dr. Rochelle Walenski warned of the dangers of too many Americans failing to comply with COVID-related restrictions -19.
President Biden suggested that if this trend continues, the United States could see a fourth surge in COVID-19 infections.
Compared to the United States, European countries are lagging behind in the implementation of vaccination programs. The World Health Organization reported that only 10% of the European population received one dose of the vaccine, and only 4% received two doses.
One of the reasons for this lag is the European Union’s dependence on the AstraZeneca vaccine, which is plagued by troubles – in particular, many countries report complications after this vaccine associated with blood clotting. The Netherlands on Friday followed the example of Germany, which stopped using the vaccine for people under 60.
Blood clots are extremely rare with this vaccine. The European Medicines Agency has said the AstraZeneca vaccine is safe.
“We have to be careful, so it would be wise now to hit the pause button as a precautionary measure,” said Dutch Health Minister Hugo de Jonge.